HYRIMOZ (adalimumab-adaz)

**Product type:** Human Prescription Drug

**Active ingredient:** ADALIMUMAB

**Strength:** 80 mg/.8mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Cordavis Limited

**Marketing category:** BLA (BLA761071)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]